Ingredion Appoints Univar as Exclusive Pharma Distributor While Stevia Market Hits $1.71B by 2031
Ingredion has appointed Univar Solutions’ Ingredients + Specialties division as the exclusive distributor of its pharmaceutical starch and excipient portfolio in the United States and Canada. The global stevia market is forecast to rise from USD1.03 billion in 2026 to USD1.71 billion by 2031 at a 10.62% CAGR.
1. Distribution Agreement with Univar Solutions
Ingredion has entered a strategic partnership with Univar Solutions’ Ingredients + Specialties division, granting Univar exclusive rights to distribute Ingredion’s pharmaceutical starches and functional excipients in the United States and Canada. The agreement covers products including UNI-PURE® F, FL, GA and WG-220, expanding Ingredion’s market reach in tablet and softgel applications via Univar’s extensive network.
2. Stevia Market Growth Forecast
Analysts project the global stevia market will grow at a 10.62% CAGR from USD 1.03 billion in 2026 to USD 1.71 billion by 2031, supported by increasing regulatory validation and demand for plant-based sweeteners across food, beverage, pharmaceutical and nutraceutical sectors. Advances in bioconversion and precision fermentation are expected to improve stevia taste profiles and lower production costs.